XML 31 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Equity
12 Months Ended
Jan. 01, 2016
Stockholders' Equity Note [Abstract]  
Financing Receivables [Text Block]
Note 11 — Stockholders’ Equity
 
The cost that has been charged against income for stock-based compensation is set forth below (in thousands):
 
 
 
Fiscal Year Ended
 
 
 
January 1,
2016
 
January 2,
2015
 
January 3,
2014
 
Employee stock options
 
$
2,306
 
$
2,842
 
$
2,683
 
Restricted stock
 
 
485
 
 
935
 
 
999
 
Restricted stock units
 
 
452
 
 
795
 
 
589
 
Consultant compensation
 
 
61
 
 
91
 
 
218
 
Total
 
$
3,304
 
$
4,663
 
$
4,489
 
 
The Company recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations (in thousands):
 
 
 
Fiscal Year Ended
 
 
 
January 1,
2016
 
January 2,
2015
 
January 3,
2014
 
Cost of Sales
 
$
52
 
$
108
 
$
77
 
General and administrative
 
 
2,090
 
 
2,552
 
 
2,586
 
Marketing and selling
 
 
696
 
 
1,065
 
 
1,167
 
Research and development
 
 
466
 
 
938
 
 
659
 
Total stock-based compensation expense
 
 
3,304
 
 
4,663
 
 
4,489
 
Amounts capitalized as part of inventory
 
 
516
 
 
306
 
 
232
 
Total stock-based compensation
 
$
3,820
 
$
4,969
 
$
4,721
 
 
There was no net income tax benefit recognized in the consolidated statements of operations for stock-based compensation expense for non-qualified stock options, as the Company fully offsets net deferred tax assets with a valuation allowance (see Note 9).   The Company does not recognize deferred income taxes for incentive stock option compensation expense, and records a tax deduction only when a disqualified disposition has occurred (see Note 9).
 
As of January 1, 2016, there was $6.8 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan ($4.7 million for stock options and $2.1 million for restricted stock and restricted stock units). That cost was expected to be recognized over a weighted-average period of approximately two years. On February 11, 2016, under the Restated Omnibus Equity Incentive Plan, a change in control occurred resulting in the immediate vesting of all unvested equity awards outstanding under the Plan (see Note 18).
 
Stock Option Plan
 
The Amended and Restated 2003 Omnibus Equity Incentive Plan (“the Plan”) provides for various forms of stock-based incentives. To date, of the available forms of awards under the Plan, the Company has granted only stock options, restricted stock, unrestricted share grants, and restricted stock units (RSUs). Options under the plan are granted at fair market value on the date of grant, become exercisable generally over a three year period, or as determined by the Board of Directors, and expire over periods not exceeding 10 years from the date of grant. Certain option and share awards provide for accelerated vesting if there is a change in control and pre-established financial metrics are met (as defined in the Plan) (see Note 18). Grants of restricted stock outstanding under the Plan generally vest over periods of one to three years. Grants of RSUs outstanding under the Plan generally vest based on service, performance or a combination of both. As of January 1, 2016, there were 1,072,776 shares authorized and available for grants under the Plan.
 
  Assumptions
 
The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model applying the weighted-average assumptions noted in the following table. Expected volatilities are based on historical volatility of the Company’s stock. The expected term of options granted is derived from the historical exercises and post-vesting cancellations, and represents the period of time that options granted are expected to be outstanding. The Company has calculated a 7% estimated forfeiture rate based on historical forfeiture experience. The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.
 
 
 
Fiscal Year Ended
 
 
 
January 1,
2016
 
January 2,
2015
 
January 3,
2014
 
Expected dividend yield
 
 
0
%
 
0
%
 
0
%
Expected volatility
 
 
57
%
 
55
%
 
71
%
Risk-free interest rate
 
 
1.59
%
 
1.29
%
 
0.73
%
Expected term (in years)
 
 
5.57
 
 
4.12
 
 
4.12
 
 
A summary of option activity under the Plan for the year ended January 1, 2016 is presented below:
 
Options
 
Shares
(000’s)
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term (years)
 
Aggregate
Intrinsic
Value
(000’s)
 
Outstanding at January 2, 2015
 
 
3,175
 
$
7.79
 
 
 
 
 
 
 
Granted
 
 
1,155
 
 
7.81
 
 
 
 
 
 
 
Exercised
 
 
(476)
 
 
4.56
 
 
 
 
 
 
 
Forfeited or expired
 
 
(231)
 
 
10.57
 
 
 
 
 
 
 
Outstanding at January 1, 2016
 
 
3,623
 
$
8.02
 
 
6.59
 
$
3,562
 
Exercisable at January 1, 2016
 
 
2,075
 
$
7.15
 
 
4.85
 
$
3,352
 
 
A summary of unvested options activity under the Plan for the year ended January 1, 2016 is presented below:
 
Options
 
Shares
(000’s)
 
Weighted-
Average
Grant-Date
Fair Value
 
Unvested at January 2, 2015
 
 
1,090
 
$
5.92
 
Granted during the year
 
 
1,155
 
 
4.14
 
Forfeited or expired during the year
 
 
(135)
 
 
4.69
 
Vested during the year
 
 
(562)
 
 
5.29
 
Unvested at January 1, 2016 (see Note 18)
 
 
1,548
 
$
4.34
 
 
The weighted-average grant-date fair value of options granted during the fiscal years ended January 1, 2016, January 2, 2015 and January 3, 2014, were $4.14, $6.81, and $3.51 per option respectively.   The total intrinsic value of options exercised during the fiscal years ended January 1, 2016, January 2, 2015, and January 3, 2014, were $2.0 million, $5.5 million, and $3.9 million, respectively.
 
Warrants
 
On June 1, 2009, the Company issued warrants to Broadwood Partners, L.P. (“Broadwood”), pursuant to a Warrant Agreement, granting the right to purchase up to an additional 700,000 shares of Common Stock at an exercise price of $4.00 per share. In 2015, the warrants were exercised and as of January 1, 2016 there were no warrants outstanding.
 
Restricted stock
 
A summary of restricted stock activity for the year ended January 1, 2016 is presented below:
 
 
 
Shares
(000’s)
 
Weighted
Average
Grant-Date
Fair Value
per Share
 
Outstanding at January 2, 2015
 
 
247
 
$
9.41
 
Granted
 
 
34
 
 
8.62
 
Vested
 
 
(142)
 
 
11.88
 
Forfeited or expired
 
 
(15)
 
 
6.26
 
Outstanding at January 1, 2016 (see Note 18)
 
 
124
 
$
6.97
 
 
Restricted Stock Units
 
A summary of restricted stock units’ activity for the year ended January 1, 2016 is presented below:
 
 
 
Units
(000’s)
 
Weighted
Average
Grant-Date
Fair Value
per Share
 
Outstanding at January 2, 2015
 
 
156
 
$
15.14
 
Granted
 
 
230
 
 
7.60
 
Vested
 
 
(16)
 
 
9.20
 
Forfeited or expired
 
 
(31)
 
 
15.20
 
Outstanding at January 1, 2016 (see Note 18)
 
 
339
 
$
10.44